Microscopic Polyangiitis Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Microscopic Polyangiitis (MPA) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microscopic Polyangiitis (MPA) Treatment Overall Market Size
2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size: 2021 VS 2028
2.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Microscopic Polyangiitis (MPA) Treatment Players in Global Market
3.2 Top Global Microscopic Polyangiitis (MPA) Treatment Companies Ranked by Revenue
3.3 Global Microscopic Polyangiitis (MPA) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Microscopic Polyangiitis (MPA) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Microscopic Polyangiitis (MPA) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Microscopic Polyangiitis (MPA) Treatment Market Size Markets, 2021 & 2028
4.1.2 Avacopan
4.1.3 Immune Globulin
4.1.4 Rituximab Biosimilar
4.1.5 Others
4.2 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
4.2.1 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Microscopic Polyangiitis (MPA) Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
5.2.1 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Microscopic Polyangiitis (MPA) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
6.2.1 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028
6.3.2 US Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.3.3 Canada Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.3.4 Mexico Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028
6.4.2 Germany Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.3 France Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.4 U.K. Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.5 Italy Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.6 Russia Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.4.8 Benelux Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028
6.5.2 China Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.5.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.5.4 South Korea Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.5.6 India Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028
6.6.2 Brazil Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.6.3 Argentina Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028
6.7.2 Turkey Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.7.3 Israel Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
6.7.5 UAE Microscopic Polyangiitis (MPA) Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Celltrion Inc
7.1.1 Celltrion Inc Corporate Summary
7.1.2 Celltrion Inc Business Overview
7.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.1.4 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue in Global Market (2017-2022)
7.1.5 Celltrion Inc Key News
7.2 ChemoCentryx Inc
7.2.1 ChemoCentryx Inc Corporate Summary
7.2.2 ChemoCentryx Inc Business Overview
7.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.2.4 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue in Global Market (2017-2022)
7.2.5 ChemoCentryx Inc Key News
7.3 Sandoz International GmbH
7.3.1 Sandoz International GmbH Corporate Summary
7.3.2 Sandoz International GmbH Business Overview
7.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.3.4 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue in Global Market (2017-2022)
7.3.5 Sandoz International GmbH Key News
7.4 Teijin Pharma Ltd
7.4.1 Teijin Pharma Ltd Corporate Summary
7.4.2 Teijin Pharma Ltd Business Overview
7.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.4.4 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in Global Market (2017-2022)
7.4.5 Teijin Pharma Ltd Key News
7.5 TTY Biopharm Company Ltd
7.5.1 TTY Biopharm Company Ltd Corporate Summary
7.5.2 TTY Biopharm Company Ltd Business Overview
7.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.5.4 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in Global Market (2017-2022)
7.5.5 TTY Biopharm Company Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Microscopic Polyangiitis (MPA) Treatment Market Opportunities & Trends in Global Market
Table 2. Microscopic Polyangiitis (MPA) Treatment Market Drivers in Global Market
Table 3. Microscopic Polyangiitis (MPA) Treatment Market Restraints in Global Market
Table 4. Key Players of Microscopic Polyangiitis (MPA) Treatment in Global Market
Table 5. Top Microscopic Polyangiitis (MPA) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Microscopic Polyangiitis (MPA) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Microscopic Polyangiitis (MPA) Treatment Product Type
Table 9. List of Global Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Microscopic Polyangiitis (MPA) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Microscopic Polyangiitis (MPA) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Microscopic Polyangiitis (MPA) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Microscopic Polyangiitis (MPA) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Celltrion Inc Corporate Summary
Table 31. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Product Offerings
Table 32. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. ChemoCentryx Inc Corporate Summary
Table 34. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Product Offerings
Table 35. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sandoz International GmbH Corporate Summary
Table 37. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Product Offerings
Table 38. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Teijin Pharma Ltd Corporate Summary
Table 40. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Product Offerings
Table 41. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. TTY Biopharm Company Ltd Corporate Summary
Table 43. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Product Offerings
Table 44. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Microscopic Polyangiitis (MPA) Treatment Segment by Type in 2021
Figure 2. Microscopic Polyangiitis (MPA) Treatment Segment by Application in 2021
Figure 3. Global Microscopic Polyangiitis (MPA) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Microscopic Polyangiitis (MPA) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2021
Figure 8. By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 12. US Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 24. China Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
